Julien Taieb
朱利安·泰布
MD, PhD
Professor of Gastroenterology and GI Oncology, Head of GI Oncology Unit胃肠病学与胃肠肿瘤学教授兼胃肠肿瘤科主任
👥Biography 个人简介
Prof. Julien Taieb is a leading French GI oncologist and key architect of the IDEA collaboration defining optimal duration of adjuvant FOLFOX in stage III CRC. His research spans adjuvant therapy, molecular subtypes, and perioperative treatment of CRC.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Adjuvant CRC Therapy Optimization
Co-led the landmark IDEA international collaboration demonstrating non-inferiority of 3 versus 6 months of adjuvant FOLFOX/CAPOX in low-risk stage III CRC, reducing toxicity for thousands of patients globally each year.
CRC Molecular Subtyping in Clinical Practice
Advanced clinical integration of CRC molecular subtypes (CMS classification) and molecular predictors of adjuvant therapy benefit, promoting biomarker-driven adjuvant treatment decision-making in routine oncology practice.
Representative Works 代表性著作
Optimizing the Duration of Oxaliplatin-Based Adjuvant Therapy in Stage III Colon Cancer: The IDEA France Trial
Journal of Clinical Oncology (2019)
French arm of IDEA collaboration supporting 3-month adjuvant FOLFOX for low-risk stage III colon cancer.
Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer
Nature Reviews Cancer (2020)
Comprehensive analysis of CMS subtypes as predictive and prognostic tools in CRC clinical management.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 朱利安·泰布 的研究动态
Follow Julien Taieb's research updates
留下邮箱，当我们发布与 Julien Taieb（Hôpital Européen Georges-Pompidou / Université Paris Cité）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment